Back to Search
Start Over
ITM and Debiopharm Enter Licensing Agreement
- Source :
- Wireless News. September 19, 2024
- Publication Year :
- 2024
-
Abstract
- ITM Isotope Technologies Munich SE (ITM), a radiopharmaceutical biotech company and Debiopharm, a Swiss-based, global biopharmaceutical company, aiming to establish tomorrow's standard-of-care to cure cancer and infectious diseases, reported that [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- Wireless News
- Publication Type :
- News
- Accession number :
- edsgcl.809264641